EAM
Erste Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.9M | Buy |
53,397
+16,364
| +44% | +$8.54M | 0.23% | 97 |
|
2025
Q1 | $23.6M | Sell |
37,033
-3,349
| -8% | -$2.13M | 0.3% | 83 |
|
2024
Q4 | $28.6M | Sell |
40,382
-257
| -0.6% | -$182K | 0.35% | 70 |
|
2024
Q3 | $42.5M | Buy |
40,639
+1,806
| +5% | +$1.89M | 0.51% | 52 |
|
2024
Q2 | $40.8M | Sell |
38,833
-3,115
| -7% | -$3.27M | 0.54% | 52 |
|
2024
Q1 | $40.5M | Buy |
41,948
+1,068
| +3% | +$1.03M | 0.55% | 54 |
|
2023
Q4 | $36M | Buy |
40,880
+2,410
| +6% | +$2.12M | 0.53% | 56 |
|
2023
Q3 | $32.1M | Sell |
38,470
-1,383
| -3% | -$1.15M | 0.55% | 60 |
|
2023
Q2 | $28.2M | Buy |
39,853
+413
| +1% | +$293K | 0.5% | 62 |
|
2023
Q1 | $32M | Buy |
39,440
+7,292
| +23% | +$5.92M | 0.61% | 51 |
|
2022
Q4 | $23.2M | Sell |
32,148
-1,987
| -6% | -$1.43M | 0.49% | 62 |
|
2022
Q3 | $23.6M | Buy |
34,135
+857
| +3% | +$593K | 0.53% | 57 |
|
2022
Q2 | $19.9M | Buy |
33,278
+1,077
| +3% | +$644K | 0.44% | 65 |
|
2022
Q1 | $22.3M | Sell |
32,201
-1,055
| -3% | -$730K | 0.43% | 65 |
|
2021
Q4 | $21.5M | Sell |
33,256
-1,714
| -5% | -$1.11M | 0.39% | 76 |
|
2021
Q3 | $21.2M | Buy |
34,970
+3,500
| +11% | +$2.12M | 0.42% | 76 |
|
2021
Q2 | $17.2M | Sell |
31,470
-1,650
| -5% | -$901K | 0.34% | 82 |
|
2021
Q1 | $15.6M | Buy |
33,120
+250
| +0.8% | +$118K | 0.38% | 76 |
|
2020
Q4 | $15.9M | Sell |
32,870
-2,800
| -8% | -$1.36M | 0.44% | 71 |
|
2020
Q3 | $20.5M | Sell |
35,670
-330
| -0.9% | -$189K | 0.7% | 41 |
|
2020
Q2 | $22M | Buy |
36,000
+26,500
| +279% | +$16.2M | 0.88% | 27 |
|
2020
Q1 | $4.49M | Hold |
9,500
| – | – | 0.26% | 111 |
|
2019
Q4 | $3.55M | Hold |
9,500
| – | – | 0.16% | 142 |
|
2019
Q3 | $2.6M | Hold |
9,500
| – | – | 0.14% | 156 |
|
2019
Q2 | $2.95M | Sell |
9,500
-7,850
| -45% | -$2.44M | 0.16% | 138 |
|
2019
Q1 | $7.02M | Sell |
17,350
-8,550
| -33% | -$3.46M | 0.39% | 59 |
|
2018
Q4 | $9.45M | Buy |
+25,900
| New | +$9.45M | 0.63% | 36 |
|